Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04256824Phase 4Unknown
Phase 4, randomised, double-blind trial (2 arms), sponsored by ClinAmygate. Primary endpoint: Incidence of surgical site infection at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04256824.